Validating a depression screening tool for new fathers in France

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to validate the French version of the Edinburgh Postnatal Depression Scale (EPDS) for screening postnatal depression in fathers. As fatherhood evolves, it is crucial to recognize that men can also experience significant psychological challenges during the perinatal period. The study will involve administering the EPDS to fathers of newborns aged 10 days or less to assess its effectiveness as a screening tool. By validating this scale, the research seeks to improve early detection and treatment of postnatal depression in men.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* All fathers whose baby is 10 days old or less

Exclusion Criteria:

* People with a poor understanding of spoken or written French
* Minors
* Persons under court protection, guardianship or curatorship

Where it's running

• Le Havre hospital - site Jacques Monod
  Montivilliers, France Recruiting
• Antoine-Béclère hospital AP-HP
  Clamart, France Enrolling by invitation

Study contacts

• Study coordinator: Angélique PICARD, project coordinator
• Email: angelique.picard@ch-havre.fr
• Phone: +33232734856

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Brexanolone therapy for moms with postpartum depression

  This trial tests LPCN 1154A against placebo to see if it can help reduce depression symptoms in women with severe postpartum depression.

  Recruiting at 16 sites Phase 3 Lipocine Inc. · Tucson, Arizona and 15 other locations · NCT07822321

• Improving mental health and HIV care for pregnant women in Malawi

  This study is testing a new support program to see if it can help pregnant women living with HIV in Malawi feel better mentally, engage more with their HIV care, and improve their baby's health.

  Recruiting at 4 sites University of North Carolina, Chapel Hill · Lilongwe and 4 other locations · NCT06702722

• Psychoeducational intervention for new mothers to prevent postpartum depression and anxiety

  This study is testing a new support program for new mothers to see if it can help prevent postpartum depression and anxiety better than regular check-ups.

  Recruiting Fundacion Clinic per a la Recerca Biomédica · Barcelona, Barcelona and 1 other locations · NCT06512025

• TrueBlue mobile app for tracking depression and anxiety during pregnancy and after birth

  This project will test whether the TrueBlue smartphone app can monitor symptoms of depression, anxiety, and loss of pleasure in people who are pregnant or within 12 weeks after giving birth.

  Recruiting BlueSkeye AI · Nottingham, Nottinghamshire and 1 other locations · NCT06364488

• Using daily rhythms and blue light to support mental health after childbirth

  This trial will test whether daily blue light therapy helps women 4–6 weeks after childbirth reduce postpartum depression and anxiety symptoms.

  Recruiting Hospital de Clinicas de Porto Alegre · Porto Alegre, Rio Grande do Sul · NCT06246214

• HeartGPS: Prenatal psychological support for parents and babies after a single ventricle heart diagnosis

  This study tests whether an eight-session prenatal psychological program (HeartGPS) for parents of fetuses with single ventricle congenital heart disease can reduce parent distress and support fetal and infant brain and developmental outcomes.

  Recruiting Children's Hospital Medical Center, Cincinnati · Los Angeles, California and 3 other locations · NCT06175104

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.